Brazilian antitrust watchdog CADE approved with no restriction the takeover of medical diagnostics company Alliar by an investment fund linked to tycoon Nelson Tanure, the country’s official gazette showed on Friday.
Controlling shareholders of Alliar announced in November they had accepted Tanure’s bid of 20.50 reais ($3.76) per share in the company, formally known as Centro de Imagem Diagnosticos SA.
Alliar said in a securities filing that CADE’s decision will be binding after a 15-day period starting on Friday, provided there are no challenges to the body’s ruling on the transaction.
Still, the closing of the deal depends on “the completion of other normal conditions precedent for this type of transaction,” it added.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Chamber of Commerce Sues to Overturn FTC Non-Compete Ban
Apr 24, 2024 by
CPI
FTC Chief Warns of Healthcare Price Fixing Risks Amid Tech Advancements
Apr 24, 2024 by
CPI
Amazon’s Investment in Anthropic Faces Antitrust Scrutiny
Apr 24, 2024 by
CPI
Italian Antitrust Authority Fines Amazon €10 Million for Unfair Trade Practices
Apr 24, 2024 by
CPI
Tuta Mail Raises Alarm Over Google Search Ranking Plunge Amidst DMA Rollout
Apr 24, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI